PHARMACEUTICAL COMBINATIONS OF STATINS AND FIBRATES FOR THE TREATMENT AND PREVENTION OF HYPERLIPIDAEMIA AND CARDIOVASCULAR DISEASES

摘要

The present invention combines the drugs atorvastatin and fenofibrate in a single dosage unit, which represents a set of major technological challenges due to the physico-chemical properties and difference in doses required to ensure a stable product for the treatment of hyperlipidemia and prevention of cardiovascular diseases.